10:33 am February 08, 2019
The initiative will tap into emerging technologies, potentially blockchain, to improve supply chain safety and security.
01:42 pm February 06, 2019
The major academic health system is working with machine learning analytics vendor Splunk to create a new system to guard against misuse of controlled substances, including opioids.
05:23 pm January 17, 2019
Minor differences in co-payments sometimes mask exponential differences between similar generic formulations.
12:36 pm January 15, 2019
The companies will use Azure to expand and develop new platforms and networks for digital health, care management and patient engagement – and compete against companies such as Amazon.
01:01 pm December 26, 2018
Companies will look to emerging technologies, such as a virtual diabetes program and a medication adherence pilot, in an effort to combine Verily’s tech with Walgreens stores.
09:42 am December 13, 2018
Tamper-proof distributed ledger tech helps with efficiency, security, integrity and visibility of pharmacy and other supply chain data. And because it doesn't necessarily involve PHI, it may be a logical place for hospitals to start exploring.
01:05 pm December 05, 2018
Their automated identity proofing process helps providers to adhere to looming government-mandated EPCS verification standards, enabling them to approve or deny prescriptions remotely.
03:41 pm September 21, 2018
HIMSS on Friday issued a call to the healthcare industry to take action in battling the ongoing opioid crisis in America by using health information and technology.
12:31 pm September 18, 2018
With a rare near-unanimous vote, the United States Senate passed The Opioid Crisis Response Act of 2018 on Monday evening. It's a massive bill comprising a wide array of proposals drawn from five Senate committees, and has many implications for the use and funding of health IT.
02:57 pm August 31, 2018
The bipartisan legislation would require HHS to work with the private sector to analyze data from payers and pharmacists, flagging patients at risk of overuse based on prescription history.